DRIO
$7.99-0.25 (-3.03%)
DarioHealth Corp.
Recent News
DarioHealth Corp (DRIO) Q4 2025 Earnings Call Highlights: Strategic Growth Amid Revenue Challenges
DarioHealth Corp (DRIO) reports sequential revenue growth and strong gross margins, despite a decline in annual revenue due to a legacy client non-renewal.
DarioHealth Corp. Q4 2025 Earnings Call Summary
Moby summary of DarioHealth Corp.'s Q4 2025 earnings call
DarioHealth (DRIO) Q4 2025 Earnings Transcript
Erez Raphael, Chief Executive Officer of DarioHealth Corp. He will be joined by our President and Chief Commercial Officer, Steven C. Nelson, and Chen Franco-Yehuda, our Chief Financial Officer. A copy of the release can be found on the Investor Relations page of DarioHealth Corp.’s website.
DarioHealth Q4 Earnings Call Highlights
DarioHealth (NASDAQ:DRIO) executives highlighted record commercial momentum and continued cost reductions on the company’s fourth-quarter and year-end 2025 earnings call, while also addressing the revenue impact of a single legacy customer non-renewal and outlining expectations for accelerating grow
DarioHealth Corp. (DRIO) Reports Q4 Loss, Beats Revenue Estimates
DarioHealth (DRIO) delivered earnings and revenue surprises of +48.88% and +2.17%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?